...Continued

Tudor Gold Intersects 20.86 g/t AuEQ over 4.5 Meters Within 25.5 Meters of 9.96 g/t AuEQ with a 500 Meter Northeast Step-Out Hole GS-22-134 at the Goldstorm Deposit, Treaty Creek Property, Northern British Columbia

Retrieved on: 
Tuesday, July 19, 2022
Storm, CEO, Equilateral triangle, Program, ...Continued, Map, Heart, CBS, Pulse, DS5, Gold, Press release, TTF2, TUC, Treaty, FSE, Golden Triangle, Uranium, Rare-earth element, Road, Sintering

GS-22-136 stepped out on the DS5 resource area and returned 34.5 m of 2.64 g/t AuEQ within 82.7 m of 1.62 g/t AuEQ.

Key Points: 
  • GS-22-136 stepped out on the DS5 resource area and returned 34.5 m of 2.64 g/t AuEQ within 82.7 m of 1.62 g/t AuEQ.
  • GS-22-138 tested the southern boundary of the DS5 resource area and returned 33.5 m of 1.00 g/t AuEQ within 108.0 m of 0.70 g/t AuEQ.
  • A second deeper intersection returned 42.25 m of 1.03 g/t AuEQ within 79.5 m of 0.77 g/t AuEQ.
  • A second deeper intersection returned 12.0 m of 1.00 g/t AuEQ within 30.0 m of 0.67 g/t AuEQ.

SuperKlean Q3/Q4 2022 Inventory Update - Virtually All SuperKlean Products in Stock for Same Day Shipments

Retrieved on: 
Tuesday, July 12, 2022
Food, PST, Plant, ...Continued, Steam, Hot, Shelf, Forecasting, SKU, Warehouse, Hydraulic machinery

BURLINGAME, Calif., July 12, 2022 /PRNewswire-PRWeb/ -- Based on extensive studies provided by key industry forecasters, plus valuable input from NAHAD's own industry experts, SuperKlean loaded up warehouses and strengthened supply chains in mid-2019. Once the pandemic and potential for shutdowns arose, SuperKlean doubled down again and has continuously increased factory orders every quarter since. Unlike many other washdown equipment suppliers, SuperKlean's inventory is full and being shipped same day or next day to plants and factories around the world.

Key Points: 
  • Advance Planning and Major Investments in Inventory Enables SuperKlean to Offer Continued "Off the Shelf" Same Day Shipments.
  • Unlike many other washdown equipment suppliers, SuperKlean's inventory is full and being shipped same day or next day to plants and factories around the world.
  • Associated products, like SuperKlean Steam Traps, Steam Strainers, and hose swivel fittings, are often used in conjunction with SuperKlean Hose Stations.
  • For more information, feel free to call SuperKlean at 1-800-769-9173 where technical representatives knowledgeable about SuperKlean inventory can assist.

Chem-Dry Inks Deals in Greater Sacramento and San Bernadino, Expands California Presence

Retrieved on: 
Tuesday, July 12, 2022
Dorado, People, Allergen, Safety, Orange, Education, Golden State, Solution, Awareness, Maintenance, Wood, Upholstery, ...Continued, Population, Growth, Health, Industry, Kenosha County Healthy Homes Initiative, Partnership, Renewable energy, Restaurant, Chem-Dry, Entrepreneurship

SACRAMENTO, Calif., July 12, 2022 /PRNewswire/ -- Carpet and upholstery cleaning franchise leader Chem-Dry recently announced two major signed agreements in California, furthering the brand's presence in the state. One signed agreement covers the Sacramento area, and the other covers Greater San Bernadino. Chem-Dry is on the fast-track for growth in 2022, with 23 signed agreements year-to-date and a goal of adding 70 franchises by the end of the year.

Key Points: 
  • One signed agreement covers the Sacramento area, and the other covers Greater San Bernadino.
  • Heading up the recent California development for Chem-Dry in California are franchisees Cliff Mastrolia and Dada Ojeisekhoba.
  • Mastrolia's Chem-Dry territory covers Greater Sacramento, including Placer and El Dorado counties, and Ojeisekhoba's territory includes San Bernadino and Riverside counties.
  • Ojeisekhoba is located in Orange County, and has worked in the cleaning industry for over 20 years before finding Chem-Dry.

Canoe Mining Ventures Provides Corporate Update

Retrieved on: 
Monday, June 13, 2022
The Exchange, Company, TSX Venture Exchange, Forward-looking statement, Nature, News, NEX, Conversation, Risk, Indian stock exchange, ...Continued, SEDAR, Cryptocurrency, Exchange

Toronto, Ontario--(Newsfile Corp. - June 13, 2022) - Canoe Mining Ventures Corp. (TSXV: CLV) ( the "Company") announces that it has made the requisite filings with the TSX Venture Exchange (the "Exchange") to resume the trading of the common shares (each, a "Common Share") in the capital of the Company.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - June 13, 2022) - Canoe Mining Ventures Corp. (TSXV: CLV) ( the "Company") announces that it has made the requisite filings with the TSX Venture Exchange (the "Exchange") to resume the trading of the common shares (each, a "Common Share") in the capital of the Company.
  • The Common Shares were halted at the request of the Exchange, on June 6, 2022, pending Company contact.
  • The Company undertakes no obligation to update forward-looking information except as required by applicable law.
  • The reader is cautioned not to place undue reliance on and the Company relies on litigation protection for forward-looking statements.

Swvl Announces Portfolio Optimization Program to Turn Cash Flow Positive in 2023

Retrieved on: 
Tuesday, May 31, 2022
Mobility as a service, Risk, University, Company, ...Continued, NEW, City, U.S. Securities and Exchange Commission, B2G, Investment, NASDAQ, Transport, COVID-19, Failure, Efficiency, Software, Probability, Corruption, Time, Gesellschaft mit beschränkter Haftung, Compliance, Communication, Forward-looking statement, School, Software as a service, Acquisition, The Company, Growth, Business, SWVL, Risk management, Nasdaq, Swvl, Service

Such reductions will focus on roles which have been automated by investments in the Company's engineering and product and support functions.

Key Points: 
  • Such reductions will focus on roles which have been automated by investments in the Company's engineering and product and support functions.
  • As a result of the portfolio optimization program, Swvl's management currently expects that the Company will be cash flow positive in 2023.
  • Swvl is a global provider of transformative tech-enabled mass transit solutions, offering intercity, intracity, B2B and B2G transportation.
  • However, while Swvl may elect to update these forward-looking statements in the future, Swvl specifically disclaims any obligation to do so.

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

Retrieved on: 
Thursday, May 12, 2022
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, Disease, Research, U.S. Securities and Exchange Commission, Cell, WITS, EMA, University, Standard of care, Risk, Oxidative stress, Expanded access, Niemann–Pick disease, PIP, ...Continued, Organ dysfunction, Protocol, Therapy, Lysosome, Genetic disorder, Trial of the century, Senior advisor, Internet, Company, Doctor of Philosophy, Cholesterol, Science, Adult, Priority review, CYTH, NPC, University of the Witwatersrand, MD, Security (finance), Nasdaq, Patient, SOC, GSC, Form 10-K, Neuron, IND, Global, Technology, Safety, Death, CEO, Pharmaceutical industry, Medical device, NPC1, EU

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the first quarter 2022 and provided a business update.

Key Points: 
  • Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the first quarter 2022 and provided a business update.
  • In June 2021, the Company commenced the TransportNPC study evaluating Trappsol Cyclo for the treatment of NPC1, a rare, progressive and fatal genetic disorder.
  • Additionally, Cyclo Therapeutics received a positive opinion from the Paediatric Committee (PDCO) of the EMA and agreement on its Paediatric Investigation Plan (PIP) for Trappsol Cyclo.
  • Cyclo Therapeutics is also planning to evaluate Trappsol Cyclo for the treatment of Alzheimers Disease, targeting the reduction of amyloid beta and tau.

Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Retrieved on: 
Thursday, May 12, 2022
Company, ...Continued, Private Securities Litigation Reform Act, Research, Doctor of Philosophy, Tumor microenvironment, RAS, Patient, Insurance, AHR, Squamous cell carcinoma, TEAD, Pharmacokinetics, Clinical trial, D, Bristol Myers Squibb, Partnership, Stage 2, Neck, Program, Safety, Head, LinkedIn, Nivolumab, PD, Twitter, SEC, Cancer, GLOBE, Pharmaceutical industry, Hippopotamus, MD

BOSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced financial results for the first quarter ended March 31, 2022. The Company also shared updates across the pipeline, including its clinical stage programs with the continued advancement of IK-930, an oral transcriptional enhanced associate domain (TEAD) inhibitor candidate targeting the Hippo signaling pathway, and IK-175, an oral aryl hydrocarbon receptor (AHR) antagonist.

Key Points: 
  • We are excited about what is to come for the rest of 2022 and beyond as we continue Ikenas steady growth.
  • Ikena believes its available cash, cash equivalents, and marketable securities will be sufficient to meet its operating requirements through mid-2024.
  • Research and development expenses were $14.3 million for the three months ended March31, 2022, compared to $10.0 million for three months ended March31, 2021.
  • Ikena OncologyTM is focused on developing novel therapies targeting key signaling pathways that drive the formation and spread of cancer.

Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

Retrieved on: 
Thursday, May 5, 2022
D, COVID-19, U.S. Securities and Exchange Commission, Investment, Private Securities Litigation Reform Act, Twitter, Nasdaq, Fulvestrant, GLOBE, Compte rendu, Safety, Research, Disclosure, Drug discovery, Patient, Security (finance), Clinical trial, ...Continued, Annual report, AACR, HR, Risk, Therapy, Pharmaceutical industry, Renewable energy

CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported first quarter 2022 financial results and corporate highlights.

Key Points: 
  • We have continued our execution focus into 2022, as we advance our portfolio of precision medicines towards patients, said Sanjiv Patel, M.D., Relay Therapeutics president and chief executive officer.
  • Relay Therapeutics expects its current cash, cash equivalents and investments will be sufficient to fund its current operating plan into at least 2025.
  • R&D Expenses: Research and development expenses were $51.7 million for the first quarter of 2022, as compared to $30.6 million for the first quarter of 2021.
  • G&A Expenses: General and administrative expenses were $16.1 million for first quarter of 2022, as compared to $12.7 million for the first quarter of 2021.

BCE reports first quarter 2022 results

Retrieved on: 
Thursday, May 5, 2022
Workplace, OTT, COVID-19, Forward-looking statement, Investment, Mission statement, Information technology, EBITDA, U.S. Securities and Exchange Commission, Churn, Failure, SAM, Bell Media, Pacific Bell Wireless, Travel, Tablet, Tax, Public expenditure, Bell Let's Talk, ARPU, Risk, ...Continued, Climate change, Annual report, Epidemic, DSP, Lifting, Movement, BCE, NAS, Bell, Adoption, Radio, Electricity, Advertising, Government, DTC, Lists of disasters, Pandemic, Private Securities Litigation Reform Act, Public health, Language, EPS, Mental health, News, Research, Data monetization, Growth, Internet, ESG, Consultant, GHG, Bookkeeping, Risk management, Oil, Renewable energy, Television, Life insurance, Crave, Noovo

The forward-looking statements contained in this news release describe our expectations as of May 5, 2022 and, accordingly, are subject to change after such date.

Key Points: 
  • The forward-looking statements contained in this news release describe our expectations as of May 5, 2022 and, accordingly, are subject to change after such date.
  • Accordingly, our actual results could differ materially from our expectations as set forth in this news release.
  • We caution that the foregoing list of risk factors is not exhaustive and other factors could also adversely affect our results.
  • BCE is Canada's largest communications company, providing advanced Bell broadband wireless, Internet, TV, media and business communications services.

Continued Mobility, the leading provider of real time transportation benefits for automobile drivers, announced a partnership with Pearl Holding Group, a Florida based Managing General Agency.

Retrieved on: 
Tuesday, April 26, 2022
Transport, Insurance, Partnership, Pearl, Uber, Mobility, Owner-controlled insurance program, ...Continued, Ridesharing company

BOCA RATON, Fla., April 26, 2022 /PRNewswire/ -- Continued Mobility provides customers with an immediately available benefit amount to be used with the rideshare provider of their choice such as Uber or Lyft in the event of an automobile accident or mechanical breakdown.  Pearl Holding Group is one of Florida's leading providers of non-standard automobile insurance.

Key Points: 
  • As part of the partnership Pearl will now make available the protection of Continued Mobility to all their policyholders.
  • Pearl Holding Group is one of Florida's leading providers of non-standard automobile insurance.
  • Their dedication to customer service and recognition of new technology's role in the customer experience makes them a perfect partner for Continued Mobility."
  • Pearl Holding Groupis a managing general agent that has been operating in the state of Florida since 1991.